Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions (ECLIPSE)
Diabetes Mellitus, Type 2
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2
Eligibility Criteria
Inclusion Criteria:
- Self reports a diagnosis of type 2 diabetes
- HbA1c ≥7.5% but ≤12% at screening
- Currently instructed by a health care provider (HCP) to use a blood glucose meter to test blood sugar
- Has a compatible smartphone and willing to redownload apps if they change phones during the study
- Has a stable and consistent home and/or office internet connection
- Currently on at least 1 oral (by mouth) or injected anti-diabetic medication (for lowering your blood glucose) with or without insulin therapy (insulin injections or an insulin pump) at screening
Exclusion Criteria:
- Currently pregnant or planning to be pregnant in the next 12 months
- Body Mass Index < 27
- Currently using a CGM (Continuous glucose monitor) or have used a personal CGM in the past 3 months
- Currently using a OneTouch Verio Reflect meter
- For FitBit arm only: Currently uses related fitness applications (e.g., MyFitnessPal, JEFIT, Fitness Coach, Yoga-Go, etc.) or wearable device (e.g., Fitbit, Apple Watch, Garmin, Withings, etc.) in the past 6 months
Sites / Locations
- Evidation Health
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Cecelia Health
Fitbit
Noom
Welldoc
Access to live Cecelia health coach on the telephone for 1 year plus access to Cecelia health coach by text messaging (via the OneTouch Reveal mobile diabetes app). Subjects will be provided with the OneTouch Verio Reflect glucose meter and the OneTouch Reveal (OTR) diabetes app.
Fitbit Inspire 2 wearable plus 1 year subscription to premium Fitbit application. Subjects will also be provided with the OneTouch Verio Reflect glucose meter and the OneTouch Reveal (OTR) mobile diabetes app.
Noom behavioural weight loss program subscription for 1 year. Subjects will also be provided with the OneTouch Verio Reflect glucose meter and the OneTouch Reveal (OTR) mobile diabetes app.
Multi-condition support program from Welldoc subscription for 1 year. Subjects will also be provided with the OneTouch Verio Reflect glucose meter.